1. Antiarrhythmic Activity of Phytoadaptogens in Short-Term Ischemia-Reperfusion of the Heart and Postinfarction Cardiosclerosis
- Author
-
Budankova Ev, Leonid N. Maslov, A. V. Krylatov, A. G. Arbuzov, Yu. B. Lishmanov, V. N. Burkova, Yu. N. Konkovskaya, and E. A. Severova
- Subjects
medicine.medical_specialty ,Ischemia ,Panax ,Eleutherococcus ,Myocardial Reperfusion Injury ,General Biochemistry, Genetics and Molecular Biology ,Ginseng ,Internal medicine ,Rhodiola ,medicine ,Animals ,cardiovascular diseases ,Rats, Wistar ,biology ,Plant Extracts ,business.industry ,Eleutherococcus senticosus ,Arrhythmias, Cardiac ,General Medicine ,Aralia ,biology.organism_classification ,medicine.disease ,Leuzea ,Rats ,Rhodiola rosea ,Ventricular Fibrillation ,Ventricular fibrillation ,cardiovascular system ,Cardiology ,business ,Anti-Arrhythmia Agents - Abstract
A course of treatment (16 mg/kg orally during 5 days) by Aralia mandshurica or Rhodiola rosea extracts reduced the incidence of ischemic and reperfusion ventricular arrhythmias during 10-min ischemia and 10-min reperfusion. Extracts of Eleutherococcus senticosus, Leuzea carthamoides, and Panax ginseng did not change the incidence of ischemic and reperfusion arrhythmias. Chronic treatment by aralia, rhodiola, and eleutherococcus elevated the ventricular fibrillation threshold in rats with postinfarction cardiosclerosis. Ginseng and leuzea did not change this parameter in rats with postinfarction cardiosclerosis.
- Published
- 2009
- Full Text
- View/download PDF